ArticleBritish journal of cancer2015
Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer.
C-L Soh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.